Skip to main content

Table 3 Ongoing pharmacological treatment in studied groups

From: No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea

Pharmacological treatment

Number of patients receiving treatment

 

OSAS, n = 27

CPAP-OSAS, n = 22

Controls, n = 11

ACEI

12

10

2

Diuretics

11

6

1

Ca2+ channel blocker

4

5

1

Beta-blockers

4

1

1

Nitrates

4

4

1

Digitalis

3

1

0

Statins

8

6

0

Allopurinol

0

4

0

Ticlopidine

2

0

1

Gliclazide

1

5

0

  1. ACEI – angiotensin converting enzyme inhibitors; OSAS – patients with untreated OSAS; CPAP-OSAS – patients with OSAS treated successfully after a first attempt with CPAP, controls – subjects without OSAS. Four, 2, and 6 subjects were free of any medication in OSAS, CPAP-OSAS and controls group, respectively.
Back to article page

Journal of Negative Results in BioMedicine

ISSN: 1477-5751

Contact us